aluates Reports

$ 0.0

Automative

Global Nanotechnology Drug Delivery Systems Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-20T12594

Global Nanotechnology Drug Delivery Systems Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Global Nanotechnology Drug Delivery Systems Market Research Report 2024

Code: QYRE-Auto-20T12594

Report

June 2024

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Nanotechnology Drug Delivery Systems Market Size

The global Nanotechnology Drug Delivery Systems market was valued at US$ 4571.7 million in 2023 and is anticipated to reach US$ 5421.1 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.

Nanotechnology Drug Delivery Systems Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nanotechnology Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology Drug Delivery Systems.

Report Scope

The Nanotechnology Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanotechnology Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nanotechnology Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nanotechnology Drug Delivery Systems Market Report

Report Metric	Details
Report Name	Nanotechnology Drug Delivery Systems Market
Accounted market size in 2023	US$ 4571.7 million
Forecasted market size in 2030	US$ 5421.1 million
CAGR	2.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Nanocrystals Nanoparticles Dendrimers Gold Nanoparticles Fullerenes Liposomes Nanotubes Others
Segment by Application	Immunology Cardiovascular Neurology Oncology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., 3M, Zosano Pharma, Becton-Dickinson（BD）Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanotechnology Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nanotechnology Drug Delivery Systems Market growing?

Ans: The Nanotechnology Drug Delivery Systems Market witnessing a CAGR of 2.5% during the forecast period 2024-2030.

What is the Nanotechnology Drug Delivery Systems Market size in 2030?

Ans: The Nanotechnology Drug Delivery Systems Market size in 2030 will be US$ 5421.1 million.

Who are the main players in the Nanotechnology Drug Delivery Systems Market report?

Ans: The main players in the Nanotechnology Drug Delivery Systems Market are AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., 3M, Zosano Pharma, Becton-Dickinson（BD）Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG

What are the Application segmentation covered in the Nanotechnology Drug Delivery Systems Market report?

Ans: The Applications covered in the Nanotechnology Drug Delivery Systems Market report are Immunology, Cardiovascular, Neurology, Oncology, Others

What are the Type segmentation covered in the Nanotechnology Drug Delivery Systems Market report?

Ans: The Types covered in the Nanotechnology Drug Delivery Systems Market report are Nanocrystals, Nanoparticles, Dendrimers, Gold Nanoparticles, Fullerenes, Liposomes, Nanotubes, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Nanocrystals

1.2.3 Nanoparticles

1.2.4 Dendrimers

1.2.5 Gold Nanoparticles

1.2.6 Fullerenes

1.2.7 Liposomes

1.2.8 Nanotubes

1.2.9 Others

1.3 Market by Application

1.3.1 Global Nanotechnology Drug Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Immunology

1.3.3 Cardiovascular

1.3.4 Neurology

1.3.5 Oncology

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nanotechnology Drug Delivery Systems Market Perspective (2019-2030)

2.2 Nanotechnology Drug Delivery Systems Growth Trends by Region

2.2.1 Global Nanotechnology Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Nanotechnology Drug Delivery Systems Historic Market Size by Region (2019-2024)

2.2.3 Nanotechnology Drug Delivery Systems Forecasted Market Size by Region (2025-2030)

2.3 Nanotechnology Drug Delivery Systems Market Dynamics

2.3.1 Nanotechnology Drug Delivery Systems Industry Trends

2.3.2 Nanotechnology Drug Delivery Systems Market Drivers

2.3.3 Nanotechnology Drug Delivery Systems Market Challenges

2.3.4 Nanotechnology Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nanotechnology Drug Delivery Systems Players by Revenue

3.1.1 Global Top Nanotechnology Drug Delivery Systems Players by Revenue (2019-2024)

3.1.2 Global Nanotechnology Drug Delivery Systems Revenue Market Share by Players (2019-2024)

3.2 Global Nanotechnology Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Nanotechnology Drug Delivery Systems Revenue

3.4 Global Nanotechnology Drug Delivery Systems Market Concentration Ratio

3.4.1 Global Nanotechnology Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology Drug Delivery Systems Revenue in 2023

3.5 Nanotechnology Drug Delivery Systems Key Players Head office and Area Served

3.6 Key Players Nanotechnology Drug Delivery Systems Product Solution and Service

3.7 Date of Enter into Nanotechnology Drug Delivery Systems Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Nanotechnology Drug Delivery Systems Breakdown Data by Type

4.1 Global Nanotechnology Drug Delivery Systems Historic Market Size by Type (2019-2024)

4.2 Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Type (2025-2030)

5 Nanotechnology Drug Delivery Systems Breakdown Data by Application

5.1 Global Nanotechnology Drug Delivery Systems Historic Market Size by Application (2019-2024)

5.2 Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Nanotechnology Drug Delivery Systems Market Size (2019-2030)

6.2 North America Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Nanotechnology Drug Delivery Systems Market Size by Country (2019-2024)

6.4 North America Nanotechnology Drug Delivery Systems Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nanotechnology Drug Delivery Systems Market Size (2019-2030)

7.2 Europe Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Nanotechnology Drug Delivery Systems Market Size by Country (2019-2024)

7.4 Europe Nanotechnology Drug Delivery Systems Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size (2019-2030)

8.2 Asia-Pacific Nanotechnology Drug Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2019-2024)

8.4 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nanotechnology Drug Delivery Systems Market Size (2019-2030)

9.2 Latin America Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2019-2024)

9.4 Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nanotechnology Drug Delivery Systems Market Size (2019-2030)

10.2 Middle East & Africa Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2019-2024)

10.4 Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie, Inc.

11.1.1 AbbVie, Inc. Company Detail

11.1.2 AbbVie, Inc. Business Overview

11.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Systems Introduction

11.1.4 AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.1.5 AbbVie, Inc. Recent Development

11.2 Amgen Inc.

11.2.1 Amgen Inc. Company Detail

11.2.2 Amgen Inc. Business Overview

11.2.3 Amgen Inc. Nanotechnology Drug Delivery Systems Introduction

11.2.4 Amgen Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.2.5 Amgen Inc. Recent Development

11.3 Celgene Corporation

11.3.1 Celgene Corporation Company Detail

11.3.2 Celgene Corporation Business Overview

11.3.3 Celgene Corporation Nanotechnology Drug Delivery Systems Introduction

11.3.4 Celgene Corporation Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.3.5 Celgene Corporation Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Detail

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Nanotechnology Drug Delivery Systems Introduction

11.4.4 Johnson & Johnson Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.4.5 Johnson & Johnson Recent Development

11.5 Merck & Co., Inc.

11.5.1 Merck & Co., Inc. Company Detail

11.5.2 Merck & Co., Inc. Business Overview

11.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Introduction

11.5.4 Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.5.5 Merck & Co., Inc. Recent Development

11.6 Novartis International AG

11.6.1 Novartis International AG Company Detail

11.6.2 Novartis International AG Business Overview

11.6.3 Novartis International AG Nanotechnology Drug Delivery Systems Introduction

11.6.4 Novartis International AG Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.6.5 Novartis International AG Recent Development

11.7 Perrigo Company plc

11.7.1 Perrigo Company plc Company Detail

11.7.2 Perrigo Company plc Business Overview

11.7.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Introduction

11.7.4 Perrigo Company plc Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.7.5 Perrigo Company plc Recent Development

11.8 Pfizer, Inc.

11.8.1 Pfizer, Inc. Company Detail

11.8.2 Pfizer, Inc. Business Overview

11.8.3 Pfizer, Inc. Nanotechnology Drug Delivery Systems Introduction

11.8.4 Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.8.5 Pfizer, Inc. Recent Development

11.9 Teva Pharmaceutical Industries Ltd.

11.9.1 Teva Pharmaceutical Industries Ltd. Company Detail

11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Introduction

11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.10 3M

11.10.1 3M Company Detail

11.10.2 3M Business Overview

11.10.3 3M Nanotechnology Drug Delivery Systems Introduction

11.10.4 3M Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.10.5 3M Recent Development

11.11 Zosano Pharma

11.11.1 Zosano Pharma Company Detail

11.11.2 Zosano Pharma Business Overview

11.11.3 Zosano Pharma Nanotechnology Drug Delivery Systems Introduction

11.11.4 Zosano Pharma Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.11.5 Zosano Pharma Recent Development

11.12 Becton-Dickinson（BD）Technologies

11.12.1 Becton-Dickinson（BD）Technologies Company Detail

11.12.2 Becton-Dickinson（BD）Technologies Business Overview

11.12.3 Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Introduction

11.12.4 Becton-Dickinson（BD）Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.12.5 Becton-Dickinson（BD）Technologies Recent Development

11.13 Nanopass Technologies

11.13.1 Nanopass Technologies Company Detail

11.13.2 Nanopass Technologies Business Overview

11.13.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Introduction

11.13.4 Nanopass Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.13.5 Nanopass Technologies Recent Development

11.14 Corium

11.14.1 Corium Company Detail

11.14.2 Corium Business Overview

11.14.3 Corium Nanotechnology Drug Delivery Systems Introduction

11.14.4 Corium Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.14.5 Corium Recent Development

11.15 Valeritas

11.15.1 Valeritas Company Detail

11.15.2 Valeritas Business Overview

11.15.3 Valeritas Nanotechnology Drug Delivery Systems Introduction

11.15.4 Valeritas Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.15.5 Valeritas Recent Development

11.16 Nitto

11.16.1 Nitto Company Detail

11.16.2 Nitto Business Overview

11.16.3 Nitto Nanotechnology Drug Delivery Systems Introduction

11.16.4 Nitto Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.16.5 Nitto Recent Development

11.17 Microdermics

11.17.1 Microdermics Company Detail

11.17.2 Microdermics Business Overview

11.17.3 Microdermics Nanotechnology Drug Delivery Systems Introduction

11.17.4 Microdermics Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.17.5 Microdermics Recent Development

11.18 TheraJect

11.18.1 TheraJect Company Detail

11.18.2 TheraJect Business Overview

11.18.3 TheraJect Nanotechnology Drug Delivery Systems Introduction

11.18.4 TheraJect Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.18.5 TheraJect Recent Development

11.19 Vaxxas

11.19.1 Vaxxas Company Detail

11.19.2 Vaxxas Business Overview

11.19.3 Vaxxas Nanotechnology Drug Delivery Systems Introduction

11.19.4 Vaxxas Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.19.5 Vaxxas Recent Development

11.20 Lohmann Therapie-Systeme AG

11.20.1 Lohmann Therapie-Systeme AG Company Detail

11.20.2 Lohmann Therapie-Systeme AG Business Overview

11.20.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Introduction

11.20.4 Lohmann Therapie-Systeme AG Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024)

11.20.5 Lohmann Therapie-Systeme AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Nanocrystals

Table 3. Key Players of Nanoparticles

Table 4. Key Players of Dendrimers

Table 5. Key Players of Gold Nanoparticles

Table 6. Key Players of Fullerenes

Table 7. Key Players of Liposomes

Table 8. Key Players of Nanotubes

Table 9. Key Players of Others

Table 10. Global Nanotechnology Drug Delivery Systems Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Nanotechnology Drug Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Nanotechnology Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)

Table 13. Global Nanotechnology Drug Delivery Systems Market Share by Region (2019-2024)

Table 14. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 15. Global Nanotechnology Drug Delivery Systems Market Share by Region (2025-2030)

Table 16. Nanotechnology Drug Delivery Systems Market Trends

Table 17. Nanotechnology Drug Delivery Systems Market Drivers

Table 18. Nanotechnology Drug Delivery Systems Market Challenges

Table 19. Nanotechnology Drug Delivery Systems Market Restraints

Table 20. Global Nanotechnology Drug Delivery Systems Revenue by Players (2019-2024) & (US$ Million)

Table 21. Global Nanotechnology Drug Delivery Systems Market Share by Players (2019-2024)

Table 22. Global Top Nanotechnology Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology Drug Delivery Systems as of 2023)

Table 23. Ranking of Global Top Nanotechnology Drug Delivery Systems Companies by Revenue (US$ Million) in 2023

Table 24. Global 5 Largest Players Market Share by Nanotechnology Drug Delivery Systems Revenue (CR5 and HHI) & (2019-2024)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Nanotechnology Drug Delivery Systems Product Solution and Service

Table 27. Date of Enter into Nanotechnology Drug Delivery Systems Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Nanotechnology Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)

Table 30. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Type (2019-2024)

Table 31. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 32. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Type (2025-2030)

Table 33. Global Nanotechnology Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)

Table 34. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Application (2019-2024)

Table 35. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 36. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Application (2025-2030)

Table 37. North America Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Nanotechnology Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Nanotechnology Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)

Table 42. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)

Table 43. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 44. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)

Table 45. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2025-2030) & (US$ Million)

Table 46. Latin America Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)

Table 48. Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)

Table 49. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 50. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)

Table 51. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)

Table 52. AbbVie, Inc. Company Detail

Table 53. AbbVie, Inc. Business Overview

Table 54. AbbVie, Inc. Nanotechnology Drug Delivery Systems Product

Table 55. AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 56. AbbVie, Inc. Recent Development

Table 57. Amgen Inc. Company Detail

Table 58. Amgen Inc. Business Overview

Table 59. Amgen Inc. Nanotechnology Drug Delivery Systems Product

Table 60. Amgen Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 61. Amgen Inc. Recent Development

Table 62. Celgene Corporation Company Detail

Table 63. Celgene Corporation Business Overview

Table 64. Celgene Corporation Nanotechnology Drug Delivery Systems Product

Table 65. Celgene Corporation Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 66. Celgene Corporation Recent Development

Table 67. Johnson & Johnson Company Detail

Table 68. Johnson & Johnson Business Overview

Table 69. Johnson & Johnson Nanotechnology Drug Delivery Systems Product

Table 70. Johnson & Johnson Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 71. Johnson & Johnson Recent Development

Table 72. Merck & Co., Inc. Company Detail

Table 73. Merck & Co., Inc. Business Overview

Table 74. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product

Table 75. Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 76. Merck & Co., Inc. Recent Development

Table 77. Novartis International AG Company Detail

Table 78. Novartis International AG Business Overview

Table 79. Novartis International AG Nanotechnology Drug Delivery Systems Product

Table 80. Novartis International AG Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 81. Novartis International AG Recent Development

Table 82. Perrigo Company plc Company Detail

Table 83. Perrigo Company plc Business Overview

Table 84. Perrigo Company plc Nanotechnology Drug Delivery Systems Product

Table 85. Perrigo Company plc Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 86. Perrigo Company plc Recent Development

Table 87. Pfizer, Inc. Company Detail

Table 88. Pfizer, Inc. Business Overview

Table 89. Pfizer, Inc. Nanotechnology Drug Delivery Systems Product

Table 90. Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 91. Pfizer, Inc. Recent Development

Table 92. Teva Pharmaceutical Industries Ltd. Company Detail

Table 93. Teva Pharmaceutical Industries Ltd. Business Overview

Table 94. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product

Table 95. Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 96. Teva Pharmaceutical Industries Ltd. Recent Development

Table 97. 3M Company Detail

Table 98. 3M Business Overview

Table 99. 3M Nanotechnology Drug Delivery Systems Product

Table 100. 3M Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 101. 3M Recent Development

Table 102. Zosano Pharma Company Detail

Table 103. Zosano Pharma Business Overview

Table 104. Zosano Pharma Nanotechnology Drug Delivery Systems Product

Table 105. Zosano Pharma Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 106. Zosano Pharma Recent Development

Table 107. Becton-Dickinson（BD）Technologies Company Detail

Table 108. Becton-Dickinson（BD）Technologies Business Overview

Table 109. Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Product

Table 110. Becton-Dickinson（BD）Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 111. Becton-Dickinson（BD）Technologies Recent Development

Table 112. Nanopass Technologies Company Detail

Table 113. Nanopass Technologies Business Overview

Table 114. Nanopass Technologies Nanotechnology Drug Delivery Systems Product

Table 115. Nanopass Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 116. Nanopass Technologies Recent Development

Table 117. Corium Company Detail

Table 118. Corium Business Overview

Table 119. Corium Nanotechnology Drug Delivery Systems Product

Table 120. Corium Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 121. Corium Recent Development

Table 122. Valeritas Company Detail

Table 123. Valeritas Business Overview

Table 124. Valeritas Nanotechnology Drug Delivery Systems Product

Table 125. Valeritas Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 126. Valeritas Recent Development

Table 127. Nitto Company Detail

Table 128. Nitto Business Overview

Table 129. Nitto Nanotechnology Drug Delivery Systems Product

Table 130. Nitto Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 131. Nitto Recent Development

Table 132. Microdermics Company Detail

Table 133. Microdermics Business Overview

Table 134. Microdermics Nanotechnology Drug Delivery Systems Product

Table 135. Microdermics Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 136. Microdermics Recent Development

Table 137. TheraJect Company Detail

Table 138. TheraJect Business Overview

Table 139. TheraJect Nanotechnology Drug Delivery Systems Product

Table 140. TheraJect Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 141. TheraJect Recent Development

Table 142. Vaxxas Company Detail

Table 143. Vaxxas Business Overview

Table 144. Vaxxas Nanotechnology Drug Delivery Systems Product

Table 145. Vaxxas Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 146. Vaxxas Recent Development

Table 147. Lohmann Therapie-Systeme AG Company Detail

Table 148. Lohmann Therapie-Systeme AG Business Overview

Table 149. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product

Table 150. Lohmann Therapie-Systeme AG Revenue in Nanotechnology Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 151. Lohmann Therapie-Systeme AG Recent Development

Table 152. Research Programs/Design for This Report

Table 153. Key Data Information from Secondary Sources

Table 154. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Nanotechnology Drug Delivery Systems Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Nanotechnology Drug Delivery Systems Market Share by Type: 2023 VS 2030

Figure 3. Nanocrystals Features

Figure 4. Nanoparticles Features

Figure 5. Dendrimers Features

Figure 6. Gold Nanoparticles Features

Figure 7. Fullerenes Features

Figure 8. Liposomes Features

Figure 9. Nanotubes Features

Figure 10. Others Features

Figure 11. Global Nanotechnology Drug Delivery Systems Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 12. Global Nanotechnology Drug Delivery Systems Market Share by Application: 2023 VS 2030

Figure 13. Immunology Case Studies

Figure 14. Cardiovascular Case Studies

Figure 15. Neurology Case Studies

Figure 16. Oncology Case Studies

Figure 17. Others Case Studies

Figure 18. Nanotechnology Drug Delivery Systems Report Years Considered

Figure 19. Global Nanotechnology Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 20. Global Nanotechnology Drug Delivery Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 21. Global Nanotechnology Drug Delivery Systems Market Share by Region: 2023 VS 2030

Figure 22. Global Nanotechnology Drug Delivery Systems Market Share by Players in 2023

Figure 23. Global Top Nanotechnology Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology Drug Delivery Systems as of 2023)

Figure 24. The Top 10 and 5 Players Market Share by Nanotechnology Drug Delivery Systems Revenue in 2023

Figure 25. North America Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. North America Nanotechnology Drug Delivery Systems Market Share by Country (2019-2030)

Figure 27. United States Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Canada Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Europe Nanotechnology Drug Delivery Systems Market Share by Country (2019-2030)

Figure 31. Germany Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia-Pacific Nanotechnology Drug Delivery Systems Market Share by Region (2019-2030)

Figure 39. China Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Japan Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. India Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Australia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Latin America Nanotechnology Drug Delivery Systems Market Share by Country (2019-2030)

Figure 47. Mexico Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Brazil Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Nanotechnology Drug Delivery Systems Market Share by Country (2019-2030)

Figure 51. Turkey Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. AbbVie, Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 54. Amgen Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 55. Celgene Corporation Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 56. Johnson & Johnson Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 57. Merck & Co., Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 58. Novartis International AG Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 59. Perrigo Company plc Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 60. Pfizer, Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 62. 3M Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 63. Zosano Pharma Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 64. Becton-Dickinson（BD）Technologies Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 65. Nanopass Technologies Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 66. Corium Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 67. Valeritas Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 68. Nitto Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 69. Microdermics Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 70. TheraJect Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 71. Vaxxas Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 72. Lohmann Therapie-Systeme AG Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2019-2024)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-31X2542

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

ELISA Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6C4296

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Blow-Fill-Seal (BFS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22N3952

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Membrane Technology in Pharma, Biopharma, And Life Science - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5A6999

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Nanotechnology Drug Delivery Systems Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-20T12594

Global Nanotechnology Drug Delivery Systems Market Research Report 2024

FEATURED COMPANIES

Nanotechnology Drug Delivery Systems Market Size

Nanotechnology Drug Delivery Systems Market

Report Scope

Scope of Nanotechnology Drug Delivery Systems Market Report

Chapter Outline

FAQ for this report

How fast is Nanotechnology Drug Delivery Systems Market growing?

What is the Nanotechnology Drug Delivery Systems Market size in 2030?

Who are the main players in the Nanotechnology Drug Delivery Systems Market report?

What are the Application segmentation covered in the Nanotechnology Drug Delivery Systems Market report?

What are the Type segmentation covered in the Nanotechnology Drug Delivery Systems Market report?

FEATURED COMPANIES

RELATED REPORTS